Zobrazeno 1 - 10
of 126
pro vyhledávání: '"Zoltán, Csanádi"'
Autor:
Tímea Papp, György Rokszin, Zoltán Kiss, Dávid Becker, Béla Merkely, Zoltán Járai, András Jánosi, Zoltán Csanádi
Publikováno v:
Cardiology and Therapy, Vol 13, Iss 3, Pp 615-630 (2024)
Abstract Introduction Atrial fibrillation (AF) and heart failure (HF) often coexist due to the common elements of the pathomechanism they share. The potential significance of the order these entities present in the same patient is ill-defined. Herein
Externí odkaz:
https://doaj.org/article/49abe426dc194af8862255597e0bb37c
Autor:
Krisztina Mária Szabó, Anna Tóth, László Nagy, Vivien Rácz, Zsófia Pólik, Katalin Hodosi, Attila C. Nagy, Judit Barta, Attila Borbély, Zoltán Csanádi
Publikováno v:
Cardiology and Therapy, Vol 13, Iss 1, Pp 149-161 (2024)
Abstract Introduction Non-responders to cardiac resynchronization therapy (CRT-NR) have poor prognosis. Sacubitril/valsartan (SV) treatment improved the outcome of patients with heart failure with reduced left ventricular (LV) ejection fraction (HFrE
Externí odkaz:
https://doaj.org/article/86ef03ae63f2481eae9ef5e34dd24a87
Autor:
Arnold Péter Ráduly, Attila Tóth, Fruzsina Sárkány, Balázs Horváth, Norbert Szentandrássy, Péter P. Nánási, Zoltán Csanádi, István Édes, Zoltán Papp, Attila Borbély
Publikováno v:
ESC Heart Failure, Vol 10, Iss 2, Pp 1326-1335 (2023)
Abstract Aims Heart failure with reduced ejection fraction (HFrEF) is a disease with high mortality and morbidity. Recent positive inotropic drug developments focused on cardiac myofilaments, that is, direct activators of the myosin molecule and Ca2+
Externí odkaz:
https://doaj.org/article/884f94be9dcb4a8dbf784c50e3b45f24
Publikováno v:
Arthritis Research & Therapy, Vol 24, Iss 1, Pp 1-11 (2022)
Abstract Background Cardiac involvement in patients with idiopathic inflammatory myopathies (IIM) is associated with increased morbidity and mortality risk; however, little is known about the progression of cardiac dysfunction and long-term data are
Externí odkaz:
https://doaj.org/article/fdd7f413e34b4e9a9b75de38e587c151
Autor:
Ádám Illési, Zsolt Fejes, Marianna Pócsi, Ildikó Beke Debreceni, Katalin Hodosi, Béla Nagy Jr., János Kappelmayer, Zsolt Kőszegi, Zoltán Csanádi, Tibor Szük
Publikováno v:
Journal of Clinical Medicine, Vol 12, Iss 21, p 6829 (2023)
Percutaneous coronary intervention (PCI) is a frequently performed treatment option for recanalization in patients with chronic total occlusion (CTO). As CTO-PCIs are often complicated and challenging for interventionalists, the stressful and damagin
Externí odkaz:
https://doaj.org/article/4ce9d2bbc7754fcf95b694ec239fb17f
Autor:
Réka Urbancsek, Zoltán Csanádi, Ildikó Noémi Forgács, Tímea Bianka Papp, Judit Boczán, Judit Barta, Csaba Jenei, László Nagy, László Rudas
Publikováno v:
ESC Heart Failure, Vol 8, Iss 6, Pp 5112-5120 (2021)
Abstract Aim While sympathetic overactivity in heart failure (HF) with reduced ejection fraction (HFrEF; EF
Externí odkaz:
https://doaj.org/article/9b0773bf2069465d90637bc27a150f84
Autor:
Gábor Csató, Nóra Erdei, Beatrix Ványai, Tímea Balla, Dániel Czuriga, Zoltán Csanádi, Zsolt Koszegi, István Édes, Gábor Tamás Szabó
Publikováno v:
Frontiers in Cardiovascular Medicine, Vol 9 (2022)
AimsIn-stent restenosis (ISR) is an unresolved problem following percutaneous coronary intervention (PCI), having a negative impact on clinical outcome. The main goal of this study was to find new independent predictors that may influence the develop
Externí odkaz:
https://doaj.org/article/6ae04beac0ad4a7b9acd1945ace4476b
Autor:
Lilla Szuromi, Orsolya Hajas, Edina Nagy-Baló, Ildikó N. Forgács, László T. Nagy, Miklós Fagyas, Attila Tóth, Béla Nagy Jr, János Kappelmayer, Zoltán Csanádi
Publikováno v:
Reviews in Cardiovascular Medicine, Vol 24, Iss 6, p 171 (2023)
Background: Atrial fibrillation (AF) is accompanied by inflammation and fibrosis to variable extent. The biomarkers of fibrosis were measured in patients with different forms of AF and cardiac status. Herein, we assessed the associations of the basel
Externí odkaz:
https://doaj.org/article/260193083361440d87283254de28529d
Publikováno v:
Journal of Personalized Medicine, Vol 13, Iss 5, p 780 (2023)
Atrial fibrillation (AF) is the most common arrhythmia in myocardial infarction (MI). AF can be caused by ischemia, and MI can be caused by AF. Additionally, 4–5% of MI cases are related to coronary embolism (CE), and one-third of cases are attribu
Externí odkaz:
https://doaj.org/article/afef68e303294949bbab3250f1cc6c06
Publikováno v:
ESC Heart Failure, Vol 8, Iss 1, Pp 171-174 (2021)
Externí odkaz:
https://doaj.org/article/0d885ad8df9048e8b413492a9b34b229